What is the first-line treatment for Gonorrhea?

What is the first-line treatment for Gonorrhea?

• A. Ampicillin
• B. Ceftriaxone
• C. Tetracycline
• D. Metronidazole

Answer: (B)

The first-line treatment for gonorrhea is ceftriaxone, which is a third-generation cephalosporin antibiotic. This medication is effective against Neisseria gonorrhoeae, the bacterium responsible for the infection. Current treatment guidelines emphasize the use of ceftriaxone due to its efficacy and the increasing resistance seen with other antibiotics. Ceftriaxone is often administered as an intramuscular injection, which provides rapid therapeutic levels in the body. The combination with azithromycin is recommended to also cover possible co-infection with Chlamydia trachomatis and combat antimicrobial resistance. Utilizing ceftriaxone helps ensure a successful treatment outcome, especially as resistance patterns evolve and impact the effectiveness of other antibiotics. This approach aligns with the latest clinical guidelines from organizations like the CDC, which continually update protocols to reflect resistance trends and improve patient care in the management of sexually transmitted infections.

The first-line treatment for gonorrhea is ceftriaxone, which is a third-generation cephalosporin antibiotic. This medication is effective against Neisseria gonorrhoeae, the bacterium responsible for the infection. Current treatment guidelines emphasize the use of ceftriaxone due to its efficacy and the increasing resistance seen with other antibiotics.

Ceftriaxone is often administered as an intramuscular injection, which provides rapid therapeutic levels in the body. The combination with azithromycin is recommended to also cover possible co-infection with Chlamydia trachomatis and combat antimicrobial resistance.

Utilizing ceftriaxone helps ensure a successful treatment outcome, especially as resistance patterns evolve and impact the effectiveness of other antibiotics. This approach aligns with the latest clinical guidelines from organizations like the CDC, which continually update protocols to reflect resistance trends and improve patient care in the management of sexually transmitted infections.